Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. | Johnson & Johnson

Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.

09/21/2021

DownloadPDF 161 KB

Multimedia Files:

Questions? Please contact us:

investor-relations@its.jnj.com